Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Finati
Observed names:
Dr Marco Finati,
Marco FINATI
Institutions:
University of Foggia,
Ospedali Riuniti di Foggia
Observed institutions:
University of Foggia,
Henry Ford Health,
Vita-Salute San Raffaele University,
Henry Ford Hospital,
Ospedali Riuniti di Foggia,
Ospedale Papa Giovanni XXIII,
IRCCS Ospedale San Raffaele,
University of Milano-Bicocca
show all 8
ORCID:
0000-0002-7425-1166
Observed ORCID:
0000-0002-7425-1166
OpenAlex ID:
A5036982883
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
2023
·
Biagio Barone
, Marco Finati
, et al.
·
Journal of Personalized Medicine
·
64
Liquid Biopsy: Current advancements in clinical practice for bladder cancer
2025
·
Felice Crocetto
, Ugo Amicuzi
, et al.
·
The Journal of Liquid Biopsy
·
47
PDF
Urobiome and Inflammation: A Systematic Review on Microbial Imbalances and Diagnostic Tools for Urinary Disorders
2025
·
Sara Palumbo
, Giuseppe Lucarelli
, et al.
·
Urology
·
35
The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre
2020
·
Richard Naspro
, Marco Finati
, et al.
·
World Journal of Urology
·
23
Robot‐assisted nephroureterectomy: surgical and mid‐term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
2024
·
Francesco Ditonno
, Antonio Franco
, et al.
·
British Journal of Urology
·
21
PDF
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
2023
·
Ugo G. Falagario
, Anna Lantz
, et al.
·
World Journal of Urology
·
17
PDF
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
2024
·
Francesco DITONNO
, Antonio FRANCO
, et al.
·
Minerva Urology and Nephrology
·
15
Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model
2024
·
Giuseppe Chiarelli
, Alex Stephens
, et al.
·
International Urology and Nephrology
·
15
Impact of low-intensity extracorporeal shockwave therapy on vascular parameters and sexual function in patients with arteriogenic erectile dysfunction
2024
·
Matteo Rubino
, Anna Ricapito
, et al.
·
Asian Journal of Andrology
·
14
The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry
2024
·
Courtney Yong
, James E. Slaven
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
13
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes
2024
·
Dhruv Puri
, Margaret F. Meagher
, et al.
·
British Journal of Urology
·
12
PDF
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation
2023
·
Oscar Selvaggio
, Marco Finati
, et al.
·
International Urology and Nephrology
·
12
PDF
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
2024
·
Gabriele Tuderti
, Riccardo Mastroianni
, et al.
·
World Journal of Urology
·
11
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohort
2024
·
Marco Finati
, Alex Stephens
, et al.
·
JNCI Cancer Spectrum
·
9
PDF
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
2024
·
Francesco Ditonno
, Antonio Franco
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
9
Refining Active Surveillance Eligibility in Intermediate-risk Non–muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence
2025
·
Marco Finati
, Nicola Schiavone
, et al.
·
European Urology Open Science
·
8
Single bladder instillation of gemcitabine versus mitomycin C after minimally invasive radical nephroureterectomy: A propensity-score match analysis from the ROBUUST 2.0 collaborative group
2025
·
Eugenio Bologna
, Zhenjie Wu
, et al.
·
Asian journal of urology
·
8
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis
2023
·
Giuseppe Ottone Cirulli
, Nicholas Corsi
, et al.
·
British Journal of Urology
·
8
Oncological outcomes of concomitant carcinoma in situ at radical cystectomy in pure urothelial bladder cancer and in histological variants.
2021
·
Richard Naspro
, Giovanni La Croce
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
8
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
2025
·
Francesco DITONNO
, Antonio FRANCO
, et al.
·
Minerva Urology and Nephrology
·
7
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
2023
·
Gian Maria Busetto
, Marco Finati
, et al.
·
World Journal of Urology
·
7
PDF
Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohort
2024
·
Marco Finati
, Alex Stephens
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
6
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort
2024
·
Marco Finati
, Matthew Davis
, et al.
·
European Urology Oncology
·
6
The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy
2022
·
Giovanni La Croce
, Richard Naspro
, et al.
·
Journal of Clinical Medicine
·
6
PDF
Comparison of patient background between a real‐world North American cohort and the Göteborg‐2 trial
2024
·
Giuseppe Chiarelli
, Matthew Davis
, et al.
·
International Journal of Urology
·
5
Show more works
View as search
Works count:
101
Citation count:
445
H-index:
12
I10-index:
13
Year
Topic
Type